• Most countries do not even report on their drug-resistant TB situation.

  • Data sets for most cohorts are incomplete, unpublished, or unvalidated.

  • There is no rigorous, randomized evidence for the standard of care for MDR TB.

Harrington noted that data are crucial to mounting the necessary response to the crisis. He cited data as one of the key elements that enabled activists to transform the struggle against HIV, saying, “We brought data to policy makers and scientists, and we used the data to demand money, services, and the nation’s attention.”

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement